Form 4: Harmony Biosciences Director Acquires Stock Options
SEC Form 4
Director Juan A. Sabater acquired 6,336 stock options in Harmony Biosciences Holdings, Inc. on May 29, 2024.
Summary
- On May 29, 2024, Juan A. Sabater, a director of Harmony Biosciences Holdings, Inc., acquired 6,336 stock options.
- The exercise price of these options is $29.33.
- The options vest fully on the earlier of May 29, 2025, or the date of the next annual meeting following the grant date, contingent upon continued service.
- The expiration date for these options is May 29, 2034.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing the acquisition of stock options by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders and their holdings in the company's stock.
Stakeholder Impact
- The acquisition of stock options by a director could be perceived positively by shareholders as it aligns the director's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 05/29/2024 | Date of earliest transaction: Juan A. Sabater acquired 6,336 stock options. |
| 05/29/2025 | Stock options vest fully on the earlier of this date or the next annual meeting following the grant date, subject to continued service. |
| 05/29/2034 | Expiration date of the stock options. |
| 05/31/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.